-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
In recognition of the outstanding contributions made in the fight against the new crown pneumonia epidemic, the CPC Central Committee decided to carry out the "Order of the Republic" and the national honorary title award.
on the basis of repeated comparison and collective research between relevant regions and departments, and on the basis of organized inspection and overall consideration, a "Republican Medal" proposed candidate, three national honorary title recommended candidates. In order to fully promote democracy, listen widely to opinions and accept social supervision, the
will now make public the candidates concerned from 3 August 2020 until 7 August 2020.
if you have any objection to the proposed candidate, please report it to the Office of the Party and the State Merit Honors And Recognition Committee by telephone, mail, letter, etc. during publicity.
Phone/Fax: (010) 55604356 E-mail: gxrybz2020@163.com Mail Address: 19th ZIP Code: 100032 Party and National Merit Honors Recognition Committee Office August 3, 2020 "Medal of the Republic" recommendation Candidate Zhong Nanshan Zhong Nanshan, male, Han nationality, Communist Party member, born in October 1936, Xiamen, Fujian Province, Guangzhou Medical University affiliated with the First Hospital National Respiratory Disease Clinical Medical Research Center Director, Chinese Academy of Engineering, the 11th and 12th National People's Congress representatives, the eighth, ninth and 10th National Committee of the Chinese People's Political Consultative Conference.
his long-term commitment to major respiratory infectious diseases and chronic respiratory diseases research, prevention and treatment, fruitful results and outstanding achievements.
after the outbreak of xinguan pneumonia, he dare to speak out, put forward the existence of "people-to-human" phenomenon, stressed strict prevention and control, led the writing of the new crown pneumonia diagnosis and treatment program, in the epidemic prevention and control, critical treatment, scientific research and other aspects to make outstanding contributions.
won the first prize of the National Science and Technology Progress Award and the title of "National Advanced Worker" and "Reform Pioneer".
proposed candidates for the national honorary title (in order of last name stroke) Zhang Buri, male, Han nationality, communist party member, born in February 1948, Hebei Ningjin, deputy secretary of the Party Committee of Tianjin University of Traditional Chinese Medicine, president, academician of the Chinese Academy of Engineering, the 11th, 12th and 13th National People's Congress representatives.
he has long been committed to the modernization of Chinese medicine research, lay the foundation of quality education of Chinese medicine and the standardization of international education, and promote the development of Chinese medicine heritage and innovation.
after the outbreak of xinguan pneumonia, he presided over the study and formulation of a combination of Chinese and Western medicine treatment program, guide the whole process of Chinese medicine intervention in the treatment of new crown pneumonia, achieved remarkable results, for the epidemic prevention and control to make a significant contribution.
won the first prize of the National Science and Technology Progress Award and the title of "National Excellent Communist Party Member" and "National Advanced Worker". zhang Dingyu,
, male, Han, communist party member, born in December 1963, Henan, Henan, Deputy Director of the Hubei Provincial Health Committee, Director of Wuhan Jinyintan Hospital.
he has long worked in the first line of medical care, has led the team to Wenchuan earthquake relief, many times to participate in international medical assistance.
On December 29, 2019, after the first batch of seven patients with unexplained pneumonia, he immediately set up an isolation zone, took the lead in collecting samples for virus testing, organized the mobilization of body donations, won time to confirm the new coronavirus, and created the conditions for the development of a new coronary pneumonia pathology study.
as a frozen patient, he rushed in front, led the Jinyintan Hospital cadres and workers to treat a total of more than 2,800 patients with new crown pneumonia, in order to win the Hubei defense war, Wuhan defense war made a major contribution.
was awarded the title of "Advanced individual in the prevention and control of the new crown pneumonia epidemic in the National Health System".
Chen Wei, female, Han nationality, Communist Party member, born in February 1966, Zhejiang Lanxi, Director of the Institute of Biological Engineering, Institute of Military Medical Research, Military Academy of Sciences, Research Fellow.
deputies to the 12th National People's Congress and members of the 13th National Committee of the Chinese People's Political Consultative Conference.
her long-term commitment to biohazard prevention and control research, the development of our army's first SARS prevention biopharmaceutical drug "recombinant human interferon", the world's first approved new drug certificate of Ebola vaccine.
after the outbreak of xinguan pneumonia, she rushed to Wuhan to carry out scientific research and prevention and control guidance tasks, in basic research, vaccines, protective drugs research and development has made significant achievements, for the epidemic prevention and control to make a significant contribution.
won the title of "advanced individual in the whole army to prevent SARS" and "Top Ten Outstanding Young People in China".
source: Xinhua News Agency,!-- content display ends -- !-- determine whether the login ends.